DarioHealth shareholders authorize reverse stock split and increase in authorized shares

DarioHealth Corp.

All seven director nominees elected with majority support; Hila Karah received the most 'against' votes (1.98M).
Kesselman & Kesselman (PwC) ratified as independent auditor for FY2025; 40.1M for, 146k against.
Amended 2020 Equity Compensation Plan approved; adds 6% annual share increase and authorizes RSU grants.
Reverse stock split (2:1 to 25:1) authorized; implementation by Sept 15, 2025, at Board's discretion.
Authorized common stock increased from 160M to 400M shares; approved by stockholders.

item 5.07

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.